Stryker sets its sights on Utah expansion

By Catherine Sturman
Established in Salt Lake City since 2011, situated in over 100 countries worldwide and accumulating over $11 billion in annual sales in 2016, medical te...

Established in Salt Lake City since 2011, situated in over 100 countries worldwide and accumulating over $11 billion in annual sales in 2016, medical technology company Stryker is set to expand its manufacturing capabilities in Utah.

Adding over 500 new jobs within 10 years, the development will enable the accumulation of over $16 million in new state revenue and will bring approximately $100 million in capital investment. This year, the company gained fifth spot on Fortune Magazine’s “World’s Most Admired Companies” on its list of the “Medical Equipment Industry.”

Its facility in Utah will continue to manufacture orthopaedic, spinal and endoscopic products, but now encompass a growing research and development focus, expanding its portfolio within the life science industry.

Related stories

It will also see the wages for staff to exceed over 100% of the average wage in the region.

“Since the establishment of Stryker in Utah, we’ve benefited from the talented workforce and first-rate education, research, and healthcare facilities in the area,” commented Mark Paul, President of Stryker’s neurovascular division. “We are excited to continue our expansion of Stryker’s operations and partner with state and local government in the future.”

Theresa Foxley, president and CEO of the Economic Development Corporation of Utah also said: “Stryker has cemented itself as a leader in global innovation and medical device manufacturing. With their continued expansion in Utah, Stryker adds to an already recognised and established life sciences and medical device manufacturing hub.”

Share

Featured Articles

McKinsey: Women More Likely to die of Heart Attack Than Men

McKinsey Health Institute's Lucy Pérez says cardiovascular disease top killer of women yet physicians don't know their heart attack symptoms are different

Novo Nordisk Buys $1bn Cardior in CardioVascular Move

As Novo Nordisk expands into heart medicines, we profile the Danish pharma giant who in 1923 was the first to make insulin commercially available

Shoddy Chinese Syringes Sees BD Ramp-up Production

Becton Dickinson – a major supplier of syringes – said it has upped manufacturing in its US facilities after FDA warning on China-made products

AI Tool 'Picks up Early-stage Breast Cancers Doctors Missed'

Technology & AI

AstraZeneca Buys $2bn Fusion in Next-gen Cancer Drugs Move

Medical Devices & Pharma

Eli Lilly and Amazon Pharmacy Partner on Drugs Delivery

Digital Healthcare